Abstract
Introduction: Acute kidney injury (AKI) affects 20% of hospitalized patients and worsens outcomes. To limit complications, post-discharge follow-up and kidney function testing are advised. The objective of this study was to evaluate the frequency of follow-up after discharge among AKI survivors. Methods: This was a population-based cohort study of adult Olmsted County residents hospitalized with an episode of stage II or III AKI between 2006 and 2014. Those dismissed from the hospital on dialysis, hospice, or who died within 30 days after discharge were excluded. The frequency and predictors of follow-up, defined as an outpatient serum creatinine (SCr) level or an in-person healthcare visit after discharge were described. Results: In the 627 included AKI survivors, the 30-day cumulative incidence of a follow-up outpatient SCr was 80% (95% confidence interval [CI]: 76% and 83%), a healthcare visit was 82% (95% CI: 79 and 85%), or both was 70% (95% CI: 66 and 73%). At 90 days and 1 year after discharge, the cumulative incidences of meeting both follow-up criteria rose to 82 and 91%, respectively. Independent predictors of receiving both an outpatient SCr assessment and healthcare visit within 30 days included lower estimated glomerular filtration rate at discharge, higher comorbidity burden, longer length of hospitalization, and greater maximum AKI severity. Age, sex, race/ethnicity, education level, and socioeconomic status did not predict follow-up. Conclusions: Among patients with moderate to severe AKI, 30% did not have follow-up with a SCr and healthcare visit in the 30-day post-discharge interval. Follow-up was associated with higher acuity of illness rather than demographic or socioeconomic factors.
References
1.
Wang
HE
, Muntner
P
, Chertow
GM
, Warnock
DG
. Acute kidney injury and mortality in hospitalized patients
. Am J Nephrol
. 2012
;35
(4
):349
–55
. .2.
Susantitaphong
P
, Cruz
DN
, Cerda
J
, Abulfaraj
M
, Alqahtani
F
, Koulouridis
I
, World incidence of AKI: a meta-analysis
. Clin J Am Soc Nephrol
. 2013
;8
(9
):1482
–93
. .3.
Chertow
GM
, Burdick
E
, Honour
M
, Bonventre
JV
, Bates
DW
. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients
. J Am Soc Nephrol
. 2005 Nov
;16
(11
):3365
–70
. .4.
James
MT
, Pannu
N
, Hemmelgarn
BR
, Austin
PC
, Tan
Z
, McArthur
E
, Derivation and external validation of prediction models for advanced chronic kidney disease following acute kidney injury
. JAMA
. 2017
;318
(18
):1787
–97
. .5.
Sawhney
S
, Marks
A
, Fluck
N
, Levin
A
, McLernon
D
, Prescott
G
, Post-discharge kidney function is associated with subsequent ten-year renal progression risk among survivors of acute kidney injury
. Kidney Int
. 2017
;92
(2
):440
–52
. .6.
Jones
J
, Holmen
J
, De Graauw
J
, Jovanovich
A
, Thornton
S
, Chonchol
M
. Association of complete recovery from acute kidney injury with incident CKD stage 3 and all-cause mortality
. Am J Kidney Dis
. 2012
;60
(3
):402
–8
. .7.
Heung
M
, Steffick
DE
, Zivin
K
, Gillespie
BW
, Banerjee
T
, Hsu
CY
, Acute kidney injury recovery pattern and subsequent risk of CKD: an analysis of veterans health administration data
. Am J Kidney Dis
. 2016
;67
(5
):742
–52
. .8.
Odutayo
A
, Wong
CX
, Farkouh
M
, Altman
DG
, Hopewell
S
, Emdin
CA
, AKI and long-term risk for cardiovascular events and mortality
. J Am Soc Nephrol
. 2017
;28
(1
):377
–87
. .9.
Siew
ED
, Liu
KD
, Bonn
J
, Chinchilli
V
, Dember
LM
, Girard
TD
, Improving care for patients after hospitalization with AKI
. J Am Soc Nephrol
. 2020 Oct
;31
(10
):2237
–41
. .10.
Kashani
K
, Rosner
MH
, Haase
M
, Lewington
AJP
, O’Donoghue
DJ
, Wilson
FP
, Quality improvement goals for acute kidney injury
. Clin J Am Soc Nephrol
. 2019 Jun
;14
(6
):941
–53
. .11.
Saran
R
, Robinson
B
, Abbott
KC
, Agodoa
LY
, Albertus
P
, Ayanian
J
, US renal data system 2016 annual data report: epidemiology of kidney disease in the USA
. Am J Kidney Dis
. 2017 Mar
;69
(3 Suppl 1
):A7
–8
. .12.
Siew
ED
, Peterson
JF
, Eden
SK
, Hung
AM
, Speroff
T
, Ikizler
TA
, Outpatient nephrology referral rates after acute kidney injury
. J Am Soc Nephrol
. 2012
;23
(2
):305
–12
. .13.
Phillips
D
, Holmes
J
, Davies
R
, Geen
J
, Williams
JD
, Phillips
AO
. The influence of socioeconomic status on presentation and outcome of acute kidney injury
. QJM
. 2018
;111
(12
):849
–57
. .14.
Barwise
A
, Juhn
YJ
, Wi
CI
, Novotny
P
, Jaramillo
C
, Gajic
O
, An individual housing-based socioeconomic status measure predicts advance care planning and nursing home utilization
. Am J Hosp Palliat Care
. 2019
;36
(5
):362
–9
. .15.
Singh
G
, Hu
Y
, Jacobs
S
, Brown
J
, George
J
, Bermudez
M
, Post-discharge mortality and rehospitalization among participants in a comprehensive acute kidney injury rehabilitation program
. Kidney360
. 2021 Jul
. Epub ahead of print.16.
Silver
S
, Adhikari
N
, Bell
C
, Chan
C
, Harel
Z
, Kitchlu
A
, Nephrologist follow-up versus usual care after an acute kidney injury hospitalization (FUSION): a randomized controlled trial
. Clin J Am Soc Nephrol
. 2021 Jul
;16
(7
):1005
–14
. .17.
St Sauver
JL
, Grossardt
BR
, Yawn
BP
, Melton
LJ
3rd, Rocca
WA
. Use of a medical records linkage system to enumerate a dynamic population over time: the Rochester epidemiology project
. Am J Epidemiol
. 2011 May
;173
(9
):1059
–68
.18.
Rocca
WA
, Yawn
BP
, St Sauver
JL
, Grossardt
BR
, Melton
LJ
3rd. History of the Rochester epidemiology project: half a century of medical records linkage in a US population
. Mayo Clin Proc
. 2012 Dec
;87
(12
):1202
–13
.19.
St Sauver
JL
, Grossardt
BR
, Leibson
CL
, Yawn
BP
, Melton
LJ
3rd, Rocca
WA
. Generalizability of epidemiological findings and public health decisions: an illustration from the Rochester epidemiology project
. Mayo Clin Proc
. 2012
;87
(2
):151
–60
. .20.
Kashani
K
, Shao
M
, Li
G
, Williams
AW
, Rule
AD
, Kremers
WK
, No increase in the incidence of acute kidney injury in a population-based annual temporal trends epidemiology study
. Kidney Int
. 2017
;92
(3
):721
–8
. .21.
Ahmed
A
, Vairavan
S
, Akhoundi
A
, Wilson
G
, Chiofolo
C
, Chbat
N
, Development and validation of electronic surveillance tool for acute kidney injury: a retrospective analysis
. J Crit Care
. 2015
;30
(5
):988
–93
. .22.
Thongprayoon
C
, Cheungpasitporn
W
, Harrison
AM
, Kittanamongkolchai
W
, Ungprasert
P
, Srivali
N
, The comparison of the commonly used surrogates for baseline renal function in acute kidney injury diagnosis and staging
. BMC Nephrol
. 2016
;17
(1
):6
–8
. .23.
Rule
AD
, Bergstralh
EJ
, Melton
LJ
, Li
X
, Weaver
AL
, Lieske
JC
. Kidney stones and the risk for chronic kidney disease
. Clin J Am Soc Nephrol
. 2009 Apr
;4
(4
):804
–11
. .24.
Melton
LJ
3rd. The threat to medical-records research
. N Engl J Med
. 1997 Nov
;337
(20
):1466
–70
. .25.
Canney
M
, Induruwage
D
, Sahota
A
, McCrory
C
, Hladunewich
MA
, Gill
J
, Socioeconomic position and incidence of glomerular diseases
. Clin J Am Soc Nephrol
. 2020 Mar
;15
(3
):367
–74
. .26.
Juhn
YJ
, Beebe
TJ
, Finnie
DM
, Sloan
J
, Wheeler
PH
, Yawn
B
, Development and initial testing of a new socioeconomic status measure based on housing data
. J Urban Health
. 2011 Oct
;88
(5
):933
–44
. .27.
Inker
LA
, Schmid
CH
, Tighiouart
H
, Eckfeldt
JH
, Feldman
HI
, Greene
T
, Estimating glomerular filtration rate from serum creatinine and cystatin C
. N Engl J Med
. 2012
;367
(1
):20
–9
. .28.
Chawla
LS
, Bellomo
R
, Bihorac
A
, Goldstein
SL
, Siew
ED
, Bagshaw
SM
, Acute kidney disease and renal recovery: consensus report of the acute disease ouality initiative (ADQI) 16 Workgroup
. Nat Rev Nephrol
. 2017
;13
(4
):241
–57
. .29.
Silver
SA
, Gerarduzzi
C
. Found in translation: reasons for optimism in the pursuit to prevent chronic kidney disease after acute kidney injury
. Can J Kidney Health Dis
. 2019 Jan
;6
(8
):2054358119868740
. .30.
Grams
ME
, Waikar
SS
, MacMahon
B
, Whelton
S
, Ballew
SH
, Coresh
J
. Performance and limitations of administrative data in the identification of AKI
. Clin J Am Soc Nephrol
. 2014 Apr
;9
(4
):682
–9
. .31.
Wu
VC
, Chueh
JS
, Chen
L
, Huang
TM
, Lai
TS
, Wang
CY
, Nephrologist follow-up care of patients with acute kidney disease improves outcomes: Taiwan experience
. Value Health
. 2020
;23
(9
):1225
–34
.32.
Karsanji
DJ
, Pannu
N
, Manns
BJ
, Hemmelgarn
BR
, Tan
Z
, Jindal
K
, Disparity between nephrologists’ opinions and contemporary practices for community follow-up after AKI hospitalization
. Clin J Am Soc Nephrol
. 2017
;12
(11
):1753
–61
. .33.
Harel
Z
, Wald
R
, Bargman
JM
, Mamdani
M
, Etchells
E
, Garg
AX
, Nephrologist follow-up improves all-cause mortality of severe acute kidney injury survivors
. Kidney Int
. 2013
;83
(5
):901
–8
. .34.
Greer
RC
, Liu
Y
, Crews
DC
, Jaar
BG
, Rabb
H
, Boulware
LE
. Hospital discharge communications during care transitions for patients with acute kidney injury: a cross-sectional study
. BMC Health Serv Res
. 2016
;16
(1
):449
–9
. .35.
Silver
SA
, Saragosa
M
, Adhikari
NK
, Bell
CM
, Harel
Z
, Harvey
A
, What insights do patients and caregivers have on acute kidney injury and posthospitalisation care? A single-centre qualitative study from Toronto, Canada
. BMJ Open
. 2018
;8
(6
):e021418
.36.
Parker
MG
, Pivert
KA
, Ibrahim
T
, Molitoris
BA
. Recruiting the next generation of nephrologists
. Adv Chronic Kidney Dis
. 2013 Jul
;20
(4
):326
–35
. .37.
Tan
J
, Mehrotra
A
, Nadkarni
GN
, He
JC
, Langhoff
E
, Post
J
, Telenephrology: providing healthcare to remotely located patients with chronic kidney disease
. Am J Nephrol
. 2018
;47
(3
):200
–7
. .38.
Hounkpatin
HO
, Fraser
SDS
, Johnson
MJ
, Harris
S
, Uniacke
M
, Roderick
PJ
. The association of socioeconomic status with incidence and outcomes of acute kidney injury
. Clin Kidney J
. 2020 Apr
;13
(2
):245
–52
. .39.
Bjornstad
EC
, Marshall
SW
, Mottl
AK
, Gibson
K
, Golightly
YM
, Charles
A
, Racial and health insurance disparities in pediatric acute kidney injury in the USA
. Pediatr Nephrol
. 2020
;35
(6
):1085
–96
. .40.
Grams
ME
, Matsushita
K
, Sang
Y
, Estrella
MM
, Foster
MC
, Tin
A
, Explaining the racial difference in AKI incidence
. J Am Soc Nephrol
. 2014
;25
(8
):1834
–41
. .© 2021 S. Karger AG, Basel
2021
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
